Holen Sie sich die Stockscreener-App
1.59
0.63%
-0.01
Handel nachbörslich:
1.44
-0.15
-9.43%
Schlusskurs vom Vortag:
$1.60
Offen:
$1.62
24-Stunden-Volumen:
200.87K
Relative Volume:
1.72
Marktkapitalisierung:
$118.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-19.57M
KGV:
-0.508
EPS:
-3.13
Netto-Cashflow:
$-17.24M
1W Leistung:
+8.16%
1M Leistung:
-4.22%
6M Leistung:
-29.33%
1J Leistung:
-39.08%
1-Tages-Spanne:
$1.5406
$1.70
1-Wochen-Bereich:
$1.33
$1.76
52-Wochen-Spanne:
$1.33
$4.20
Inhibikase Therapeutics Inc Stock (IKT) Company Profile
Firmenname
Inhibikase Therapeutics Inc
Sektor
Branche
Telefon
(302) 295-3800
Adresse
1000 N. WEST STREET, SUITE 1200, WILMINGTON
Vergleichen Sie IKT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IKT
Inhibikase Therapeutics Inc
|
1.59 | 119.23M | 0 | -19.57M | -17.24M | -3.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inhibikase Therapeutics Inc Stock (IKT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-12 | Herabstufung | H.C. Wainwright | Buy → Neutral |
Inhibikase Therapeutics Inc Aktie (IKT) Neueste Nachrichten
Will Inhibikase Therapeutics Inc. (IQT0) stock top growth indexesSwing Trade & Community Trade Idea Sharing - newser.com
Is Inhibikase Therapeutics Inc. (IQT0) stock a defensive play amid uncertaintyEarnings Summary Report & Verified High Yield Trade Plans - newser.com
Can Inhibikase Therapeutics Inc. stock reach $100 price target2025 Trade Ideas & Daily Oversold Stock Bounce Ideas - newser.com
Why Inhibikase Therapeutics Inc. (IQT0) stock fits value portfoliosTrade Ideas & Detailed Earnings Play Alerts - newser.com
Can volume confirm reversal in Inhibikase Therapeutics Inc.Rate Cut & Real-Time Volume Analysis Alerts - newser.com
Will Inhibikase Therapeutics Inc. stock recover after recent drop - newser.com
Is Inhibikase Therapeutics Inc. (IQT0) stock overpriced at current multiplesJuly 2025 Snapshot & Free Technical Pattern Based Buy Signals - newser.com
Understanding Inhibikase Therapeutics Inc.’s price movementGlobal Markets & Entry Point Confirmation Signals - newser.com
Earnings visualization tools for Inhibikase Therapeutics Inc.Earnings Overview Summary & Accurate Buy Signal Notifications - newser.com
Top chart patterns to watch in Inhibikase Therapeutics Inc.Weekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
Using data models to predict Inhibikase Therapeutics Inc. stock movementInsider Buying & Reliable Momentum Entry Alerts - newser.com
Is Inhibikase Therapeutics Inc. stock cheap compared to fundamentalsAnalyst Upgrade & Capital Efficient Trading Techniques - newser.com
Why Inhibikase Therapeutics Inc. (IQT0) stock trades below fair value2025 Market WrapUp & Safe Capital Growth Tips - newser.com
Is Inhibikase Therapeutics Inc. reversing from oversold territoryMarket Growth Report & Reliable Price Breakout Alerts - newser.com
Why Inhibikase Therapeutics Inc. (IQT0) stock is a strong analyst pickBull Run & Weekly High Momentum Picks - newser.com
Will Inhibikase Therapeutics Inc. stock beat EPS estimatesJuly 2025 Momentum & Free Expert Approved Momentum Trade Ideas - newser.com
What makes Inhibikase Therapeutics Inc. stock attractive to growth funds2025 Market Outlook & Risk Managed Investment Signals - newser.com
What institutional flow reveals about Inhibikase Therapeutics Inc.Weekly Gains Report & Smart Money Movement Tracker - newser.com
Will Inhibikase Therapeutics Inc. price bounce be sustainable2025 Stock Rankings & Expert Curated Trade Ideas - newser.com
Key resistance and support levels for Inhibikase Therapeutics Inc.2025 Price Momentum & Growth Oriented Trade Recommendations - newser.com
Signal strength of Inhibikase Therapeutics Inc. stock in tech scannersTrade Entry Summary & Weekly Watchlist of Top Performers - newser.com
Analyzing Inhibikase Therapeutics Inc. with risk reward ratio chartsMarket Performance Summary & Reliable Volume Spike Trade Alerts - newser.com
Can Inhibikase Therapeutics Inc. recover in the next quarter2025 Technical Overview & Accurate Entry and Exit Point Alerts - newser.com
Why Inhibikase Therapeutics Inc. stock is a must watch in 2025Earnings Growth Report & Reliable Volume Spike Trade Alerts - newser.com
How to build a dashboard for Inhibikase Therapeutics Inc. stockWeekly Market Summary & Real-Time Volume Triggers - newser.com
Will Inhibikase Therapeutics Inc. stock attract ESG investorsJuly 2025 Retail & Advanced Technical Signal Analysis - newser.com
Can Inhibikase Therapeutics Inc. stock maintain operating marginsPortfolio Value Report & Stepwise Trade Execution Plans - newser.com
Will Inhibikase Therapeutics Inc. (IQT0) stock profit from AI boomJuly 2025 Final Week & Risk Adjusted Buy and Sell Alerts - newser.com
How Inhibikase Therapeutics Inc. stock compares to growth peers2025 Dividend Review & Community Driven Trade Alerts - newser.com
Finanzdaten der Inhibikase Therapeutics Inc-Aktie (IKT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):